Charles River Laboratories International, Inc. has launched its Endosafe Nexus 200, expanding its endotoxin testing portfolio. The Nexus 200 is the company’s next-gen data integrity compliant, fully robotic instrument, designed to process both undiluted or complex, serial dilutions for water, in-process, and final product testing via Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology in a fully enclosed system. The system allows for data to be exported into a Laboratory Information Man...